Filing Details
- Accession Number:
- 0001787306-25-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-03 16:21:09
- Reporting Period:
- 2025-04-02
- Filing Date:
- 2025-04-03
- Accepted Time:
- 2025-04-03 16:21:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1787306 | Arcutis Biotherapeutics Inc. | ARQT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740378 | Joseph David Topper | 3027 Townsgate Road, Suite 300 Westlake Village CA 91361 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-04-02 | 9,600 | $15.80 | 182,774 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"), granted onApril 10, 2024.
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.61 to $17.26, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
